Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

about

Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.

P2860

Q46803440-EEE0DE7C-AA70-43CB-97CC-078B324E83C7

P2860

Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

Item

http://www.wikidata.org/entity/Q37799652

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@en

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@nl

type

Item

label

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@en

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@nl

prefLabel

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@en

Modulating the nitric oxide - ...... oup II pulmonary hypertension.

@nl

P1476

Modulating the nitric oxide - ...... roup II pulmonary hypertension

@en

P2093

M M Chakinala

http://www.w3.org/2001/XMLSchema#string

P2860

Uncoupled cardiac nitric oxide synthase mediates diastolic dysfunction

2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: de

Trends in prevalence and outcome of heart failure with preserved ejection fraction

Outcome of heart failure with preserved ejection fraction in a population-based study

Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility

Updated clinical classification of pulmonary hypertension.

Safety and efficacy of angiotensin-converting enzyme inhibitors in symptomatic severe aortic stenosis: Symptomatic Cardiac Obstruction-Pilot Study of Enalapril in Aortic Stenosis (SCOPE-AS).

Concentric left ventricular remodeling in endothelial nitric oxide synthase knockout mice by chronic pressure overload.

Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load.

Left ventricular function and exercise capacity

P304

15-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1742-1241.2010.02524.X

http://www.w3.org/2001/XMLSchema#string

P433

168

http://www.w3.org/2001/XMLSchema#string

P50

Brian Richard Lindman

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47508410

http://www.w3.org/2001/XMLSchema#string

P698

20939842

http://www.w3.org/2001/XMLSchema#string

P932

2978287

http://www.w3.org/2001/XMLSchema#string

Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

about

P2860

P2860

Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P50

P577

P5875

P698

P932